New EMA Filings: Speedy Review For Lanadelumab But Cemiplimab Gets Standard Treatment
Shire and Regeneron/Sanofi are among the companies that have recently submitted investigational new treatments for approval across the EU.
Shire and Regeneron/Sanofi are among the companies that have recently submitted investigational new treatments for approval across the EU.